These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18978361)

  • 1. Tunicamycin enhances the apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand in endometriotic stromal cells.
    Hasegawa A; Osuga Y; Hirota Y; Hamasaki K; Kodama A; Harada M; Tajima T; Takemura Y; Hirata T; Yoshino O; Koga K; Yano T; Taketani Y
    Hum Reprod; 2009 Feb; 24(2):408-14. PubMed ID: 18978361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells.
    Shiraishi T; Yoshida T; Nakata S; Horinaka M; Wakada M; Mizutani Y; Miki T; Sakai T
    Cancer Res; 2005 Jul; 65(14):6364-70. PubMed ID: 16024639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response.
    Jiang CC; Chen LH; Gillespie S; Kiejda KA; Mhaidat N; Wang YF; Thorne R; Zhang XD; Hersey P
    Cancer Res; 2007 Jun; 67(12):5880-8. PubMed ID: 17575157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tunicamycin enhances human colon cancer cells to TRAIL-induced apoptosis by JNK-CHOP-mediated DR5 upregulation and the inhibition of the EGFR pathway.
    Guo X; Meng Y; Sheng X; Guan Y; Zhang F; Han Z; Kang Y; Tai G; Zhou Y; Cheng H
    Anticancer Drugs; 2017 Jan; 28(1):66-74. PubMed ID: 27603596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tunicamycin sensitizes human prostate cells to TRAIL-induced apoptosis by upregulation of TRAIL receptors and downregulation of cIAP2.
    Jung YH; Lim EJ; Heo J; Kwon TK; Kim YH
    Int J Oncol; 2012 Jun; 40(6):1941-8. PubMed ID: 22426894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentration of osteoprotegerin (OPG) in peritoneal fluid is increased in women with endometriosis.
    Harada M; Osuga Y; Hirata T; Hirota Y; Koga K; Yoshino O; Morimoto C; Fujiwara T; Momoeda M; Yano T; Tsutsumi O; Taketani Y
    Hum Reprod; 2004 Oct; 19(10):2188-91. PubMed ID: 15242994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK
    Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells.
    Taniguchi H; Yoshida T; Horinaka M; Yasuda T; Goda AE; Konishi M; Wakada M; Kataoka K; Yoshikawa T; Sakai T
    Cancer Res; 2008 Nov; 68(21):8918-27. PubMed ID: 18974136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation.
    Kim EH; Yoon MJ; Kim SU; Kwon TK; Sohn S; Choi KS
    Cancer Res; 2008 Jan; 68(1):266-75. PubMed ID: 18172319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin-mediated c-myc overexpression and cytochrome c (cyt c) release result in the up-regulation of the death receptors DR4 and DR5 and the activation of caspase 3 and caspase 9, likely responsible for the TRAIL-sensitizing effect of cisplatin.
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Med Oncol; 2015 Apr; 32(4):133. PubMed ID: 25796504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade.
    Das S; Tripathi N; Preet R; Siddharth S; Nayak A; Bharatam PV; Kundu CN
    Oncotarget; 2017 Jan; 8(1):248-267. PubMed ID: 27542249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
    Yasuda T; Yoshida T; Goda AE; Horinaka M; Yano K; Shiraishi T; Wakada M; Mizutani Y; Miki T; Sakai T
    Mol Cancer Res; 2008 Dec; 6(12):1852-60. PubMed ID: 19074830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-related apoptosis-inducing ligand induces caspase-dependent interleukin-8 expression and apoptosis in human astroglioma cells.
    Choi C; Kutsch O; Park J; Zhou T; Seol DW; Benveniste EN
    Mol Cell Biol; 2002 Feb; 22(3):724-36. PubMed ID: 11784850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 15-Deoxy-Delta12,14-prostaglandin J(2) induces death receptor 5 expression through mRNA stabilization independently of PPARgamma and potentiates TRAIL-induced apoptosis.
    Nakata S; Yoshida T; Shiraishi T; Horinaka M; Kouhara J; Wakada M; Sakai T
    Mol Cancer Ther; 2006 Jul; 5(7):1827-35. PubMed ID: 16891469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over-expression of Reticulon 3 (RTN3) enhances TRAIL-mediated apoptosis via up-regulation of death receptor 5 (DR5) and down-regulation of c-FLIP.
    Lee JT; Lee TJ; Kim CH; Kim NS; Kwon TK
    Cancer Lett; 2009 Jul; 279(2):185-92. PubMed ID: 19250737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines.
    Chang CC; Kuan CP; Lin JY; Lai JS; Ho TF
    Chem Res Toxicol; 2015 Aug; 28(8):1574-83. PubMed ID: 26203587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaempferol Sensitizes Human Ovarian Cancer Cells-OVCAR-3 and SKOV-3 to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis via JNK/ERK-CHOP Pathway and Up-Regulation of Death Receptors 4 and 5.
    Zhao Y; Tian B; Wang Y; Ding H
    Med Sci Monit; 2017 Oct; 23():5096-5105. PubMed ID: 29070784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation.
    Jung EM; Park JW; Choi KS; Park JW; Lee HI; Lee KS; Kwon TK
    Carcinogenesis; 2006 Oct; 27(10):2008-17. PubMed ID: 16613838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-128 Targets the SIRT1/ROS/DR5 Pathway to Sensitize Colorectal Cancer to TRAIL-Induced Apoptosis.
    Lian B; Yang D; Liu Y; Shi G; Li J; Yan X; Jin K; Liu X; Zhao J; Shang W; Zhang R
    Cell Physiol Biochem; 2018; 49(6):2151-2162. PubMed ID: 30257253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of the tumor necrosis factor-related apoptosis inducing ligand death receptor DR5 prevents beta-amyloid neurotoxicity.
    Uberti D; Ferrari-Toninelli G; Bonini SA; Sarnico I; Benarese M; Pizzi M; Benussi L; Ghidoni R; Binetti G; Spano P; Facchetti F; Memo M
    Neuropsychopharmacology; 2007 Apr; 32(4):872-80. PubMed ID: 16936710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.